BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17612570)

  • 1. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
    Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
    Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
    Oliveira-Ferrer L; Tilki D; Ziegeler G; Hauschild J; Loges S; Irmak S; Kilic E; Huland H; Friedrich M; Ergün S
    Cancer Res; 2004 Dec; 64(24):8932-8. PubMed ID: 15604255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma.
    Cruz PV; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K
    Cancer; 2005 Jul; 104(2):354-60. PubMed ID: 15952183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas.
    Laurie NA; Comegys MM; Carreiro MP; Brown JF; Flanagan DL; Brilliant KE; Hixson DC
    Cancer Res; 2005 Dec; 65(23):11010-7. PubMed ID: 16322250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation.
    Singer BB; Scheffrahn I; Obrink B
    Cancer Res; 2000 Mar; 60(5):1236-44. PubMed ID: 10728682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
    Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
    Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
    Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
    J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
    Wu TT; Hsieh YH; Hsieh YS; Liu JY
    J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer.
    Tilki D; Irmak S; Oliveira-Ferrer L; Hauschild J; Miethe K; Atakaya H; Hammerer P; Friedrich MG; Schuch G; Galalae R; Stief CG; Kilic E; Huland H; Ergun S
    Oncogene; 2006 Aug; 25(36):4965-74. PubMed ID: 16568082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEACAM1 functionally interacts with filamin A and exerts a dual role in the regulation of cell migration.
    Klaile E; Müller MM; Kannicht C; Singer BB; Lucka L
    J Cell Sci; 2005 Dec; 118(Pt 23):5513-24. PubMed ID: 16291724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
    Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
    Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
    Martínez-Iglesias O; Garcia-Silva S; Tenbaum SP; Regadera J; Larcher F; Paramio JM; Vennström B; Aranda A
    Cancer Res; 2009 Jan; 69(2):501-9. PubMed ID: 19147563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
    Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
    Xu KS; Wang HF; Qian W; Wang BH
    Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
    Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.